Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16619692rdf:typepubmed:Citationlld:pubmed
pubmed-article:16619692lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:16619692lifeskim:mentionsumls-concept:C1332051lld:lifeskim
pubmed-article:16619692lifeskim:mentionsumls-concept:C0679199lld:lifeskim
pubmed-article:16619692pubmed:issue9 Suppllld:pubmed
pubmed-article:16619692pubmed:dateCreated2006-4-19lld:pubmed
pubmed-article:16619692pubmed:abstractTextStrategies to circumvent or lessen the myelotoxicity associated with combination chemotherapy may improve the overall outcome of the management of patients particularly in resource poor settings.lld:pubmed
pubmed-article:16619692pubmed:languageenglld:pubmed
pubmed-article:16619692pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16619692pubmed:citationSubsetIMlld:pubmed
pubmed-article:16619692pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16619692pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16619692pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16619692pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16619692pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16619692pubmed:statusMEDLINElld:pubmed
pubmed-article:16619692pubmed:monthSeplld:pubmed
pubmed-article:16619692pubmed:issn0012-835Xlld:pubmed
pubmed-article:16619692pubmed:authorpubmed-author:OremJJlld:pubmed
pubmed-article:16619692pubmed:authorpubmed-author:FeuerGGlld:pubmed
pubmed-article:16619692pubmed:authorpubmed-author:Katongole-Mbi...lld:pubmed
pubmed-article:16619692pubmed:authorpubmed-author:HarringtonW...lld:pubmed
pubmed-article:16619692pubmed:authorpubmed-author:RemickS CSClld:pubmed
pubmed-article:16619692pubmed:authorpubmed-author:RochfordRRlld:pubmed
pubmed-article:16619692pubmed:authorpubmed-author:MwandaW OWOlld:pubmed
pubmed-article:16619692pubmed:authorpubmed-author:BanuraCClld:pubmed
pubmed-article:16619692pubmed:authorpubmed-author:MoormannAAlld:pubmed
pubmed-article:16619692pubmed:issnTypePrintlld:pubmed
pubmed-article:16619692pubmed:volume82lld:pubmed
pubmed-article:16619692pubmed:ownerNLMlld:pubmed
pubmed-article:16619692pubmed:authorsCompleteYlld:pubmed
pubmed-article:16619692pubmed:paginationS155-60lld:pubmed
pubmed-article:16619692pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:16619692pubmed:meshHeadingpubmed-meshheading:16619692...lld:pubmed
pubmed-article:16619692pubmed:meshHeadingpubmed-meshheading:16619692...lld:pubmed
pubmed-article:16619692pubmed:meshHeadingpubmed-meshheading:16619692...lld:pubmed
pubmed-article:16619692pubmed:meshHeadingpubmed-meshheading:16619692...lld:pubmed
pubmed-article:16619692pubmed:meshHeadingpubmed-meshheading:16619692...lld:pubmed
pubmed-article:16619692pubmed:meshHeadingpubmed-meshheading:16619692...lld:pubmed
pubmed-article:16619692pubmed:meshHeadingpubmed-meshheading:16619692...lld:pubmed
pubmed-article:16619692pubmed:meshHeadingpubmed-meshheading:16619692...lld:pubmed
pubmed-article:16619692pubmed:year2005lld:pubmed
pubmed-article:16619692pubmed:articleTitleStrategies to overcome myelotoxic therapy for the treatment of Burkitt's and AIDS-related non-Hodgkin's lymphoma.lld:pubmed
pubmed-article:16619692pubmed:affiliationDepartment of Microbiology and Immunology, SUNY Upstate Medical University, Syracuse, NY 13210, USA.lld:pubmed
pubmed-article:16619692pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16619692pubmed:publicationTypeReviewlld:pubmed